Orphan Papers and Ghostwriting: The Case against the ICMJE Criterion of Authorship

Accountability in Research

Volumn 20, Issue 2, 2013, Pages 59-71

  Moffatt, Barton ^a  

^a MISSISSIPPI STATE UNIVERSITY   (United States)

Author keywords

authorship; ghostwriting; ICMJE; orphan papers; WAME

Indexed keywords

ARTICLE; ETHICS; INTERNATIONAL COOPERATION; MEDICAL RESEARCH; PUBLICATION; PUBLISHING; STANDARD; WRITING;

AUTHORSHIP; BIOMEDICAL RESEARCH; EDITORIAL POLICIES; INTERNATIONALITY; PERIODICALS AS TOPIC;

EID: 84874503888     PISSN: 08989621     EISSN: 15455815     Source Type: Journal    
DOI: 10.1080/08989621.2013.767115     Document Type: Article

References (18)

1. Bhopal, R., Rankin, J., McColl, E., Thomas, L., Kaner, E., Stacy, R., Pearson, P., Vernon, B. and Rodgers, H. 1997. The vexed question of authorship: views of researchers in a British medical faculty. BMJ, 314: 1009
2. Flanigan, A., Carey, L. A., Fontanarosa, P. B., Phillips, S. G., Pace, B. P., Lundberg, G. D. and Rennie, D. 1998. Prevalence of articles with honorary authors and ghost authors in peer reviewed medical journals. JAMA, 280: 222-224.
3. Fugh-Berman, A. 2005. The corporate coauthor. Journal of General Internal Medicine, 20: 546-548.
4. Fugh-Berman, A. 2010. The haunting of medical journals: how ghostwriting sold "HRT.". PLoS Medicine, 7: e1000335
5. Gøtzsche, P. C., Hróbjartsson, A., Johansen, H. K., Haahr, M. T., Altman, D. G. and Chan, A. 2007. Ghostauthorship in industry-initiated randomized trials. PLoS Medicine, 4: e19
6. Gøtzsche, P. C., Kassirer, J. P., Woolley, K. L., Wager, E., Jacobs, A., Gertel, A. and Hamilton, C. 2009. What should be done to tackle ghostwriting in the medical literature?. PLoS Medicine, 6: e23
7. International Committee of Medical Journal Editors (ICMJE). (2011). Uniform requirements for manuscripts submitted to biomedical journals: Writing and editing for biomedical publications. http://www.icmje.org/ (Accessed: 4 July 2011).
8. Matheson, A. 2011. How industry uses the ICMJE guidelines to manipulate authorship-and how they should be revised. PLoS Medicine, 8: e1001072
9. Moffatt, B. 2011. Responsible authorship: Why researchers must forgo honorary authorship. Accountability in Research, 18: 76-90.
10. Moffatt, B. and Elliott, C. 2007. Ghost marketing: Pharmaceutical companies and ghostwritten journal articles. Perspectives in Biology and Philosophy, 50: 18-31.
11. Mowatt, G., Shirran, L., Grimshaw, J. M., Rennie, D., Flanagin, A., Yank, V., MacLennan, G., Gøtzsche, P. C. and Bero, L. A. 2002. Prevalence of articles with honorary authors and ghost authors in Cochrane reviews. JAMA, 287: 2769-2771.
12. Rennie, D., Yank, V. and Emanuel, L. 1997. When authorship fails: A proposal to make contributors accountable. JAMA, 278: 579-585.
13. Resnik, D. 1997. A proposal for a new system of credit allocation in science. Science and Engineering Ethics, 3: 237-243.
14. Shamoo, A. and Resnik, D. 2009. Responsible Conduct of Research, 2nd, New York: Oxford University Press.
15. Sismondo, S. 2007. Ghost management: How much of the medical literature is shaped behind the scenes by the pharmaceutical industry?. PLoS Medicine, 4: e286
16. Wislar, J., Flanagin, A., Fontanarosa, P. B. and DeAngelis, C. D. 2011. Honorary and ghost authorship in high impact biomedical journals: Across sectional survey. BMJ, 343: d6128
17. World Association of Medical Editors (WAME). (2007). Criteria for authorship. http://www.wame.org/resources/policies#authorship (Accessed: 4 June 2011).
18. World Association of Medical Editors (WAME). (2012). Authorship. http://www.wame.org/resources/publication-ethics-policies-for-medical-journals#authorship (Accessed: 30 November 2012).